10.1371/journal.pone.0102760 PLoS One 79 ZhengC.GuoS.TennantW
Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options
Lukacs-Kornek, V
L.BoothS
But it uncrumples the dynamic lines (the lines that appear where your face moves) and some of the static lines
Cancer Res 82:CT108CT108 Schuhmacher J, Heidu S, Balchen T, Richardson JR, Schmeltz C, Sonne J, Schweiker J, Rammensee HG, Thor Straten P et al (2020) Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial